Browsing by Title
Now showing items 113809-113828 of 121333
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 1998-10-06)Bacterial infections are treated by the administration of alpha-interferon at a dosage of from about 0.1 to about 5 IU/lb./day such that the interferon is held in contact with the patient's oral and pharyngeal mucosae. The ...
-
(2023-04-27)The purpose of this study was to determine whether the use of microabrasion with MI Paste Plus™ (GC America) provided a significant benefit in reducing carious White Spot Lesion (WSL) surface area compared to using MI Paste ...
-
(Texas A&M University, 1985)Not available
-
(Texas, UNITED STATES, )
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2017-06-13)A method of treating or preventing a gum disease or gum disorder or gum injury in a mammal by administering to the mammal at least one inflammation modulatory or anti-inflammatory protein or polypeptide, such as TSG-6 ...
-
(Texas A&M University, 1971)Not available
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 1999-03-16)Hyperallergenic conditions are treated by the administration of interferon at a dosage of from about 0.01 to about 5 IU/lb./day such that the interferon is held in contact with the patient's oral and pharyngeal mucosae. ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 1991-05-28)Neoplastic disease, hyperallergenicity, autoimmune disorders characterized by chronic tissue degenerative inflammation and immuno-resistant viral infections are treated by the administration of interferon at a dosage of ...
-
(Antimicrobial Agents and Chemotherapy, 1984)
-
(Texas A&M University, 1964)Not available
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 1993-10-12)The invention relates to a method for increasing blood flow to the retina and choroid in subjects with decreased retinal or choroidal blood flow. The method involves the topical administration of metoclopramide and is ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 1993-11-30)The invention relates to a method for increasing blood flow to the retina and choroid in subjects with decreased retinal or choroidal blood flow. The method involves the topical administration of droperidol and is useful ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 1993-10-12)The invention relates to a method for increasing blood flow to the retina and choroid in subjects with decreased retinal or choroidal blood flow. The method involves the topical administration of loxapine and is useful for ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 1998-10-20)Neoplastic diseases are treated by the administration of human interferon, particularly IFN-α, at a dosage of from about 0.01 to about 5 IU/lb./day such that the interferon is held in contact with the patient's oral and ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 1988-09-20)Aqueous humor formation and intraocular pressure in mammals having ocular hypertension or glaucoma may be reduced by topically administering to a hypertensive eye an ophthalmologically acceptable amount of certain dopamine ...
-
(Energy Systems Laboratory (http://esl.eslwin.tamu.edu), 1991-06)The removal and recovery of organic contaminants from aqueous streams by pervaporation membrane systems is a viable and economical treatment for many waste streams. Specific opportunities for the technology are identified ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2012-07-03)Disclosed are antibodies that block the binding of fibronectin protein to fibronectin. Also disclosed are site specifically-mutated and truncated peptide epitopes derived from the fnbA and fnbB genes of Staphylococcus ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2013-06-18)The present invention is drawn to methods of stimulating or enhancing angiogenesis in a patient comprising, administering to said patient a therapeutically effective amount of an endorepellin protein, wherein said endorepellin ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 1998-11-03)Viral infections are treated by the administration of alpha-interferon at a dosage of from about 0.01 to about 5 IU/lb./day such that the interferon is held in contact with the patient's oral and pharyngeal mucosae. The ...